We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Hilltop Holdings
HTH
$2.27B
| $346K | ﹤0.01% |
11,046
-2,400
| -18% | -$72.9K |
|
1327
Banner Corp
BANR
$2.5B
| $345K | ﹤0.01% |
6,944
+1,400
| +25% | +$64.4K |
|
1328
Rocket Lab Corp
RKLB
$52.2B
| $344K | ﹤0.01% |
71,700
| – | – |
|
|
CWAN
1329
DELISTED
Clearwater Analytics
CWAN
| $343K | ﹤0.01% |
+18,500
| New | +$334K |
|
1330
Flywire
FLYW
$2.15B
| $341K | ﹤0.01% |
20,800
+5,100
| +32% | +$96.3K |
|
1331
ImmunityBio
IBRX
$8.14B
| $341K | ﹤0.01% |
+53,900
| New | +$355K |
|
1332
Pacira BioSciences
PCRX
$952M
| $341K | ﹤0.01% |
11,923
+2,300
| +24% | +$65.5K |
|
|
AIV
1333
Aimco
AIV
$378M
| $340K | ﹤0.01% |
41,048
+11,100
| +37% | +$89.5K |
|
|
SAFE
1334
Safehold
SAFE
$1.09B
| $340K | ﹤0.01% |
17,643
+6,600
| +60% | +$127K |
|
1335
Remitly
RELY
$5.25B
| $336K | ﹤0.01% |
27,700
| – | – |
|
1336
Addus HomeCare
ADUS
$2.21B
| $335K | ﹤0.01% |
2,883
| – | – |
|
1337
AtriCure
ATRC
$2.23B
| $335K | ﹤0.01% |
14,700
+1,300
| +10% | +$30K |
|
1338
Huron Consulting
HURN
$2.38B
| $335K | ﹤0.01% |
3,400
| – | – |
|
1339
Ingevity
NGVT
$2.62B
| $334K | ﹤0.01% |
7,637
| – | – |
|
|
AVDX
1340
DELISTED
AvidXchange
AVDX
| $333K | ﹤0.01% |
27,600
+3,800
| +16% | +$43.4K |
|
1341
Oxford Industries
OXM
$550M
| $333K | ﹤0.01% |
3,326
| – | – |
|
1342
Agilon Health
AGL
$1.47B
| $332K | ﹤0.01% |
2,028
+348
| +21% | +$49.6K |
|
|
ALEX
1343
DELISTED
Alexander & Baldwin
ALEX
| $332K | ﹤0.01% |
19,603
+3,900
| +25% | +$64.1K |
|
1344
National Beverage
FIZZ
$2.93B
| $332K | ﹤0.01% |
6,483
| – | – |
|
1345
Tecnoglass Holdings Inc.
TGLS
$1.87B
| $331K | ﹤0.01% |
6,600
+2,200
| +50% | +$115K |
|
1346
BancFirst
BANF
$3.87B
| $330K | ﹤0.01% |
3,758
| – | – |
|
1347
The GEO Group
GEO
$4.12B
| $330K | ﹤0.01% |
23,000
-24,100
| -51% | -$340K |
|
|
WIRE
1348
DELISTED
Encore Wire Corp
WIRE
| $330K | ﹤0.01% |
1,137
-1,700
| -60% | -$479K |
|
1349
Trustmark
TRMK
$2.81B
| $329K | ﹤0.01% |
10,960
-3,800
| -26% | -$109K |
|
1350
National Vision
EYE
$1.57B
| $327K | ﹤0.01% |
25,000
+9,400
| +60% | +$154K |
|
Similar funds
VIA
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.